A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy

C1Q and STAB1 represent candidate biomarkers of early efficacy of allergen immunotherapy as the hallmark of a regulatory innate immune response predictive of clinical tolerance.